Riskpilot← Back to searchSign inGet full accessShinaMed AB
ABBankruptOrg 5590995311Medical specialists activities · NACE 8622Est. 20170 employees
Revenue 2024
SEK 49K
+113% vs 2023
EBITDA margin
827.7%
+223% vs 2023
Equity ratio
-416.9%
Financial strength
Net profit 2024
SEK 363K
+207% vs 2023
| Revenue | SEK 49K | +113% |
| EBITDA | SEK 402K | +223% |
| Net profit | SEK 363K | +207% |
| Total assets | SEK 74K | +50% |
| Equity | SEK -310K | +54% |
| Employees | 0 | — |
Legal name
ShinaMed AB
Org number
5590995311
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
2 februari 2017
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva läkarvård. Bolaget skall även bedriva bemanningsföretag med inriktning inom vården. Bolaget skall även bedriva handel och förvaltning av värdepapper.
Address
Email
shina_kamran@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 212 | 2 478 | 835 | 23 | 49 |
| Staff expenses | — | — | −537 | −74 | −0 |
| EBITDA | 357 | 429 | −539 | −327 | 402 |
| Depreciation & amort. | −65 | −65 | −65 | −6 | — |
| EBIT | 292 | 364 | −604 | −333 | 402 |
| Net financials | −87 | −21 | −38 | −6 | −39 |
| Profit before tax | 204 | 203 | −502 | −339 | 363 |
| Tax | −84 | −99 | — | — | — |
| Net profit | 120 | 104 | −502 | −339 | 363 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 923 | 1 121 | 348 | 50 | 74 |
| Equity | 184 | 168 | −334 | −673 | −310 |
| Long-term debt | 353 | 298 | 175 | 130 | 0 |
| Short-term debt | 387 | 515 | 507 | 593 | 384 |
| Total debt | 740 | 813 | 682 | 723 | 384 |
EBITDA margin
827.7%
This company
15.8%
Market median
+5139% vs market
20202024
Equity ratio
-416.9%
This company
38.2%
Market median
-1191% vs market
20202024
Return on equity
36296300.0%
This company
18.4%
Market median
+197262400% vs market
20202024
Net profit margin
746.5%
This company
8.1%
Market median
+9116% vs market
20202024
Asset turnover
0.65×
This company
1.12×
Market median
-42% vs market
20202024
Debt / equity
1.24×
This company
0.62×
Market median
-100% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-09-01 – 2020-08-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2021 | |
| Former (1) | ||
| Deputy Board Member | 2021 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ShinaMed AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Alan Celiker | Deputy Board Member | 0 companies |
| Biyan Kaya | Deputy Board Member | 0 companies |
| Shina Kamran Hagh | Board of Directors | 0 companies |